Concepedia

Michael Millenson

MM

49

Publications

8.7K

Citations

31

H-Index

1996

Active since

Affiliations

Fox Chase Cancer Center(Current)

Memorial Sloan Kettering Cancer Center

Dana-Farber Cancer Institute

Roswell Park Comprehensive Cancer Center

The University of Texas MD Anderson Cancer Center

Michael Millenson is an author at Fox Chase Cancer Center specializing in medicine, oncology, and pathology.

Top concepts

Publications per year

1996–2018

49

Publications

49

PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma

Stephen M. Ansell, Alexander M. Lesokhin, Ivan Borrello et al. · New England Journal of Medicine · 2014 · 3.5K citations · Full text

Nivolumab in Patients With Relapsed or Refractory Hematologic Malignancy: Preliminary Results of a Phase Ib Study

Alexander M. Lesokhin, Stephen M. Ansell, Philippe Armand et al. · Journal of Clinical Oncology · 2016 · 1K citations · Full text

An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era

Zheng Zhou, Laurie H. Sehn, Alfred Rademaker et al. · Blood · 2013 · 934 citations · Full text

Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma

John P. Leonard, Ann S. LaCasce, Mitchell R. Smith et al. · Blood · 2012 · 291 citations · Full text

Myelodysplastic Syndromes

P Greenberg, Eyal C. Attar, John M. Bennett et al. · Journal of the National Comprehensive Cancer Network · 2011 · 289 citations · Full text

Rows per page

1–5 of 49